help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0441
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/10/2440    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebert, R.
Right arrow Articles by Jakob, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebert, R.
Right arrow Articles by Jakob, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*UniGene
Molecular Endocrinology 18 (10): 2440-2450
Copyright © 2004 by The Endocrine Society

Down-Regulation by Nuclear Factor {kappa}B of Human 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Promoter

Regina Ebert, Marlena Jovanovic, Matthias Ulmer, Doris Schneider, Jutta Meissner-Weigl, Jerzy Adamski and Franz Jakob

Orthopedic Department (R.E., M.J., M.U., D.S., J.M.-W., F.J.), University of Wuerzburg, Wuerzburg, Germany; and Institute of Experimental Genetics (J.A.), GSF-National Research Center for Environment and Health, Neuherberg, Germany

Address all correspondence and requests for reprints to: Franz Jakob, M.D., Experimental and Clinical Osteology, Orthopedic Department, University of Wuerzburg, Brettreichstrasse 11, D-97074 Wuerzburg, Germany. E-mail: f-jakob. klh{at}mail.uni-wuerzburg.de.

1,25-(OH)2 vitamin D3 is important for calcium homeostasis and cell differentiation. The key enzyme for the activation of liver-derived 25(OH) vitamin D3 is 25-hydroxyvitamin D3 1{alpha}-hydroxylase. It is expressed mainly in the kidney but also in peripheral tissues. A 1413-bp fragment of the 1{alpha}-hydroxylase promoter was cloned into luciferase vectors pGL2basic and pGL3basic. Sequence analyses revealed four base exchanges and three base deletions compared with the published sequence which were identically found in five control persons. In silico promoter analyses revealed 17 putative nuclear factor (NF){kappa}B sites, 10 of which were found to bind NF{kappa}B in EMSA experiments. Cotransfection of NF{kappa}B p50 and p65 subunits resulted in dramatic reduction of the promoter activity of the full-length construct as well as a series of 5'-deletion constructs. Deletion of the farmost 3'-situated NF{kappa}B-responsive element almost abolished NF{kappa}B responsiveness. Treatment of human embryonic kidney 293 cells with sulfasalazine, a NF{kappa}B inhibitor, resulted in enhanced 1{alpha}-hydroxylase mRNA production. Down-regulation of 1{alpha}-hydroxylase promoter through NF{kappa}B signaling may contribute to the pathogenesis of inflammation-associated osteopenia/osteoporosis.




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Liu, L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison
Altered Endocrine and Autocrine Metabolism of Vitamin D in a Mouse Model of Gastrointestinal Inflammation
Endocrinology, October 1, 2008; 149(10): 4799 - 4808.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
R. R. Miller, G. E. Hicks, M. D. Shardell, A. R. Cappola, W. G. Hawkes, J. A. Yu-Yahiro, A. Keegan, and J. Magaziner
Association of Serum Vitamin D Levels With Inflammatory Response Following Hip Fracture: The Baltimore Hip Studies
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1402 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. M. Turunen, T. W. Dunlop, C. Carlberg, and S. Vaisanen
Selective use of multiple vitamin D response elements underlies the 1 {alpha} ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene
Nucleic Acids Res., April 10, 2007; (2007) gkm179v1.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. van Driel, M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen
Evidence for auto/paracrine actions of vitamin D in bone: 1{alpha}-hydroxylase expression and activity in human bone cells
FASEB J, November 1, 2006; 20(13): 2417 - 2419.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
T. Ohnesorg, B. Keller, M. H. de Angelis, and J. Adamski
Transcriptional regulation of human and murine 17{beta}-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis.
J. Mol. Endocrinol., August 1, 2006; 37(1): 185 - 197.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P. P Dwivedi, P. H Anderson, J. L Omdahl, H L. Grimes, H. A Morris, and B. K May
Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells
Endocr. Relat. Cancer, June 1, 2005; 12(2): 351 - 365.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society